As a central element in healthcare, clinical diagnostics contributes to every stage of patient care: predisposition, prevention, diagnostics, treatment monitoring and prognosis.
With hundreds of thousands of clinical diagnostic tests performed every day, the laboratories of the Eurofins clinical diagnostic services business line strive to ensure that every patient, wherever he or she lives, has access to the most specialized and most innovative techniques for diagnosis, monitoring and therapeutic decisions.
Genetics and genomics are gradually marking out the new outlines of tomorrow‘s clinical diagnostics and our laboratories are investing heavily in advanced genetic technologies. Eurofins Clinical Diagnostics network of companies has a broad portfolio of genetic tests with well-known applications such as Non Invasive Prenatal Testing (NIPT), the screening of hereditary cancers, cardiovascular disease predisposition testing, rare diseases diagnosis, and personalized medicine applications that can help patients and their care providers select individualized treatment based on their genetic and metabolic profiles.
At Eurofins, we are having a growing panel of genetic tests with the following focuses:
- Reproductive Medicine
- Women's Health
- Oncology
- Cardiology
- Transplantation
- Infectious Diseases
- Neurology
- Companion Diagnostics
- COVID-19 Testing
To understand more about what Eurofins MGS can offer in terms of clinical diagnostic services in Hong Kong and for clinical testing service providers around the world, please feel free to contact our business development manager. You can email us at info@moderngenomic.com to express your interest and need, and we will respond to your enquiry as soon as we can. We look forward to providing our best support to our clients and a long-term business relationship with you.